(Q44686998)

5 December 2017

Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes (English)

1 reference

5 December 2017

1 reference

S X Zhang

1

1 reference

5 December 2017

J Sima

2

1 reference

5 December 2017

C Shao

3

1 reference

5 December 2017

J Fant

4

1 reference

5 December 2017

Y Chen

5

1 reference

5 December 2017

B Rohrer

6

1 reference

5 December 2017

G Gao

7

1 reference

5 December 2017

J-x Ma

8

1 reference

5 December 2017

10 December 2003

1 reference

5 December 2017

8

1 reference

inferred from page(s)

published in

Diabetologia

1 reference

5 December 2017

47

1 reference

5 December 2017

1

1 reference

5 December 2017

124-131

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-003-1276-4

5 December 2017

0 references

cites work

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas

1 reference

12 December 2020

Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5

1 reference

12 December 2020

Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416

1 reference

12 December 2020

Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats

1 reference

12 December 2020

Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

1 reference

12 December 2020

Oxygen-induced retinopathy in the mouse

1 reference

12 December 2020

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

1 reference

12 December 2020

Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen

1 reference

12 December 2020

Permeability of the blood-ocular barrier in adolescent and adult diabetic patients

1 reference

12 December 2020

Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

1 reference

12 December 2020

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

1 reference

12 December 2020

Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.

1 reference

12 December 2020

Distribution of albumin in the normal monkey eye as revealed by Evans blue fluorescence microscopy.

1 reference

12 December 2020

Role of vascular endothelial growth factor in diabetic vascular complications

1 reference

12 December 2020

Diabetic macular edema. A review

1 reference

12 December 2020

Molecular mechanisms of vascular permeability in diabetic retinopathy

1 reference

12 December 2020

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

1 reference

12 December 2020

Animal models of diabetic retinopathy

1 reference

12 December 2020

Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry

1 reference

12 December 2020

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

1 reference

12 December 2020

Localization of putative dopamine D2-like receptors in the chick retina, using in situ hybridization and immunocytochemistry

1 reference

12 December 2020

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

1 reference

12 December 2020

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

1 reference

12 December 2020

VEGF-initiated blood-retinal barrier breakdown in early diabetes.

1 reference

12 December 2020

The 14-year incidence of visual loss in a diabetic population.

1 reference

12 December 2020

Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth

1 reference

12 December 2020

Sensitive blood-retinal barrier breakdown quantitation using Evans blue

1 reference

12 December 2020

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

12 December 2020

1 reference

12 December 2020

Diabetic macular edema: risk factors and concomitants

1 reference

12 December 2020

Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases

1 reference

12 December 2020

Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium--derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization

1 reference

12 December 2020

Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies

1 reference

12 December 2020

Signaling via vascular endothelial growth factor receptors

1 reference

12 December 2020

1 reference

12 December 2020

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

12 December 2020

10.1007/S00125-003-1276-4

Identifiers

DOI

1 reference

5 December 2017

1 reference